LeConte Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$252K Buy
482
+16
+3% +$8.77K 0.13% 145
2026
Q2
$245K Sell
466
-21
-4% -$11.8K 0.13% 127
2026
Q1
$274K Buy
487
+37
+8% +$23.7K 0.18% 102
2025
Q4
$304K Buy
450
+75
+20% +$51.1K 0.2% 82
2025
Q3
$240K Buy
+375
New +$228K 0.16% 103

Other funds holding IDXX

LeConte Wealth Management's IDXX Position: Q3 2026 in Review

LeConte Wealth Management increased its Idexx Laboratories (IDXX) stake by 3.4% in Q3 2026, buying an estimated $8.77K and bringing the position to 482 shares worth $252K. The position accounts for 0.13% of the portfolio, ranked #145.

LeConte Wealth Management first reported a position in IDXX in Q3 2025 and has held it in 5 quarters since. The position peaked at $304K in Q4 2025. 1,272 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • LeConte Wealth Management held 482 shares of Idexx Laboratories worth $252K as of Q3 2026.
  • LeConte Wealth Management bought 16 Idexx Laboratories shares in Q3 2026, an estimated $8.77K.
  • Idexx Laboratories made up 0.13% of LeConte Wealth Management's portfolio in Q3 2026, its #145 holding.
  • LeConte Wealth Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 5 quarters since.
  • LeConte Wealth Management's Idexx Laboratories position peaked at $304K in Q4 2025.
  • 1,272 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on LeConte Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.